WELLS FARGO & COMPANY/MN - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 81 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,999
+5.0%
23,750
-20.1%
0.00%
Q1 2023$4,759
-92.6%
29,740
-74.2%
0.00%
Q4 2022$63,941
-84.7%
115,210
-67.2%
0.00%
Q3 2022$418,000
+44.6%
350,941
-23.2%
0.00%
Q2 2022$289,000
-72.0%
456,795
-49.5%
0.00%
Q1 2022$1,032,000
-60.7%
905,187
-22.5%
0.00%
-100.0%
Q4 2021$2,627,000
-53.9%
1,167,478
-29.9%
0.00%0.0%
Q3 2021$5,695,000
+22680.0%
1,665,241
+19653.7%
0.00%
Q2 2021$25,000
-13.8%
8,430
-6.1%
0.00%
Q1 2021$29,000
+52.6%
8,982
+1.5%
0.00%
Q4 2020$19,000
+90.0%
8,848
+0.6%
0.00%
Q3 2020$10,000
+25.0%
8,791
-0.3%
0.00%
Q2 2020$8,0000.0%8,814
-9.0%
0.00%
Q1 2020$8,000
-75.8%
9,682
-72.2%
0.00%
Q4 2019$33,000
-15.4%
34,801
-7.7%
0.00%
Q3 2019$39,000
-55.2%
37,701
-22.2%
0.00%
Q2 2019$87,000
-46.0%
48,461
-43.4%
0.00%
Q1 2019$161,000
+50.5%
85,599
-5.1%
0.00%
Q4 2018$107,000
-41.5%
90,201
+33.7%
0.00%
Q3 2018$183,000
-2.1%
67,466
-31.0%
0.00%
Q2 2018$187,000
-53.7%
97,789
-49.2%
0.00%
Q1 2018$404,000
+89.7%
192,493
+83.1%
0.00%
Q4 2017$213,000
+1021.1%
105,136
+654.7%
0.00%
Q3 2017$19,000
-57.8%
13,930
-51.8%
0.00%
Q2 2017$45,000
-82.9%
28,896
-64.5%
0.00%
Q1 2017$263,000
+484.4%
81,493
+144.6%
0.00%
Q4 2016$45,000
-30.8%
33,316
-19.6%
0.00%
Q3 2016$65,000
+10.2%
41,416
-6.8%
0.00%
Q2 2016$59,000
-76.2%
44,416
-5.5%
0.00%
Q1 2016$248,000
-42.7%
47,006
-14.8%
0.00%
Q4 2015$433,000
-42.8%
55,198
-38.4%
0.00%
Q3 2015$757,000
-15.4%
89,672
+9.6%
0.00%
Q2 2015$895,000
-44.6%
81,783
-29.2%
0.00%
Q1 2015$1,616,000
+15.8%
115,504
+39.8%
0.00%
-100.0%
Q4 2014$1,396,000
+82.2%
82,629
+44.8%
0.00%
Q3 2014$766,000
+0.4%
57,058
-4.7%
0.00%
Q2 2014$763,000
+25.1%
59,868
+16.6%
0.00%
Q1 2014$610,000
+24.7%
51,354
+13.2%
0.00%
Q4 2013$489,000
-11.6%
45,369
+42.9%
0.00%
Q3 2013$553,000
+21.5%
31,745
+12.9%
0.00%
Q2 2013$455,00028,1110.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders